<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02772055</url>
  </required_header>
  <id_info>
    <org_study_id>2015CB554504-02</org_study_id>
    <nct_id>NCT02772055</nct_id>
  </id_info>
  <brief_title>Efficacy of Moxibustion Therapy With or Without Smoke for Knee Osteoarthritis</brief_title>
  <official_title>A Multicentre, Randomised, Single Blinded, Parallel-group Study of Moxa Smoke Effect in Moxibustion Treating Knee Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chengdu University of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chengdu University of Traditional Chinese Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicentre, randomised, single blinded, parallel-group design clinical trial to&#xD;
      assess the effect of moxa smoke in the treatment using moxibustion for Knee Osteoarthritis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim: To assess the effect of moxa smoke in the treatment using moxibustion for knee&#xD;
      osteoarthritis.&#xD;
&#xD;
      Design: This is a multicentre, randomised, single blinded, parallel-group design clinical&#xD;
      trial. 138 eligible participants will be randomly allocated into 2 groups (moxibustion group&#xD;
      or smoke-free moxibustion group) with a 1:1 allocation ratio, and receive 12 sessions of&#xD;
      moxibustion treatment over a period of 4 weeks, three sessions per week. Each session will&#xD;
      last 30 minutes. The whole study period is 13 weeks, with a 1 week run in period, 4 week&#xD;
      treatment phase, and 8 week follow-up phase.The participants will receive moxibustion&#xD;
      treatment at three acupoints (EX-LE04,ST35,ST36). In moxa-free smoke moxibustion group,&#xD;
      investigators place a purification device(Shenzhen Conyson Electronic Technology Co, Ltd,C200&#xD;
      moxa smoke purification device,Shenzhen,China) at the top of the moxibustion to remove the&#xD;
      moxa smoke. The primary measurement outcomes are the mean change in the global scale value of&#xD;
      the Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC) pain and function&#xD;
      scores from baseline to 4 weeks. The secondary outcomes are the Visual Analogue Scale (VAS)&#xD;
      and the patient global assessment. Investigators will assess participants at the second visit&#xD;
      (before starting moxibustion treatment) and at the 2, 4, 8, and 12 week respectively after&#xD;
      the baseline.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2016</start_date>
  <completion_date type="Actual">December 2019</completion_date>
  <primary_completion_date type="Actual">May 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the global scale value of the Western Ontario and McMaster Osteoarthritis Index(WOMAC) score</measure>
    <time_frame>4 weeks from baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the WOMAC subscales (pain, stiffness, and function)</measure>
    <time_frame>at baseline(0 week), 2 weeks, 4weeks, 8 weeks and 12 weeks later after allocation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in Visual Analogue Scale for the pain intensity</measure>
    <time_frame>Assessing participants at baseline(0 week), 2 weeks, 4weeks, 8 weeks and 12 weeks later after allocation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Patient global assessment score</measure>
    <time_frame>at 2 weeks, 4weeks, 8 weeks and 12 weeks later after allocation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">138</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>moxibustion group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Conventional moxibustion treatment for knee osteoarthritis participants.12 sessions of moxibustion treatment over a period of 4 weeks, 3 sessions per week.Each session will last 30 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>smoke-free moxibustion group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Conventional moxibustion treatment for knee osteoarthritis participants and have a purification device at the top of the moxibustion to remove the moxa smoke.12 sessions of moxibustion treatment over a period of 4 weeks, 3 sessions per week.Each session will last 30 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Moxibustion</intervention_name>
    <description>Moxibustion at three acupuncture point(EX-LE04,ST35,ST36).12 sessions of moxibustion treatment over a period of 4 weeks, 3 sessions per week.Each session will last 30 minutes.</description>
    <arm_group_label>moxibustion group</arm_group_label>
    <arm_group_label>smoke-free moxibustion group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Moxa smoke purification device</intervention_name>
    <description>Investigators place a purification device(Shenzhen Conyson Electronic Technology Co, Ltd,C200 moxa smoke purification device,Shenzhen,China) at the top of the moxibustion to remove the moxa smoke.</description>
    <arm_group_label>smoke-free moxibustion group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Participants meeting the following criteria will be included:&#xD;
&#xD;
          1. aged between 40 and 75 years&#xD;
&#xD;
          2. diagnosed with knee osteoarthritis formulated by the American College of Rheumatology&#xD;
             (ACR).&#xD;
&#xD;
          3. the average severity of knee pain not more than 7 points on a visual analogue scale&#xD;
             for most days during the past month&#xD;
&#xD;
          4. agree not have the paregoric during the whole treatment phase&#xD;
&#xD;
          5. willingness to participate in a randomized study and to sign the informed consent&#xD;
             form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Participants will be excluded if they have these experiences:&#xD;
&#xD;
          1. inflammatory diseases, including rheumatoid arthritis, cancer, traumatic injury that&#xD;
             might be related to the current knee pai&#xD;
&#xD;
          2. autoimmune disease, uncontrolled hypertension&#xD;
&#xD;
          3. diabetes mellitus requiring insulin injection&#xD;
&#xD;
          4. life-threatening cardiovascular or neurological events within the past year&#xD;
&#xD;
          5. chronic respiratory disease,a haemorrhagic disorder&#xD;
&#xD;
          6. alcohol or drug addiction&#xD;
&#xD;
          7. an active infectious disease including tuberculosis&#xD;
&#xD;
          8. a significant knee joint deformity&#xD;
&#xD;
          9. knee replacement surgery for the affected knee&#xD;
&#xD;
         10. knee arthroscopy within the past year&#xD;
&#xD;
         11. steroid injection in the knee joints within the past 3 months&#xD;
&#xD;
         12. injections in the knee joints or joint fluid injection within the past 6 months&#xD;
&#xD;
         13. accept acupuncture, moxibustion, cupping, or herbal medicine within the past 4 weeks&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yu Shuguang, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chengdu University of Traditional Chinese Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chengdu University of Traditional Chinese Medicine</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610075</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>May 10, 2016</study_first_submitted>
  <study_first_submitted_qc>May 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 13, 2016</study_first_posted>
  <last_update_submitted>February 13, 2020</last_update_submitted>
  <last_update_submitted_qc>February 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Moxa smoke</keyword>
  <keyword>Moxibustion</keyword>
  <keyword>Knee osteoarthritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

